TY - JOUR
T1 - Effectiveness of Air Filters in Allergic Rhinitis
T2 - A Systematic Review and Meta-Analysis
AU - Shih, Ming Yang
AU - Hsu, Hsueh Wen
AU - Chen, Ssu Yin
AU - Su, Ming Jang
AU - Lo, Wei Cheng
AU - Chen, Chiehfeng
N1 - Publisher Copyright:
© 2024 Ming-Yang Shih et al.
PY - 2024
Y1 - 2024
N2 - Previous studies have evaluated the effectiveness of air filters in mitigating the symptoms of allergic rhinitis (AR). However, these studies have yielded inconsistent results. This systematic review and meta-analysis was conducted to assess the effectiveness of air filters for patients with AR. For this, we comprehensively searched the PubMed, Embase, and Cochrane Library databases to identify relevant articles. The results are presented in terms of standardized mean difference (SMD) and 95% confidence intervals (CI) values with the fixed-effects model (FEM) and random-effects model (REM). Eight randomized controlled trials were included in our meta-analysis. Of these, three had a parallel design and five had a crossover design. Regarding clinical outcomes, pooled analyses performed using patients' nighttime and daytime symptom scores revealed SMD values of -0.21 (95% CI: -0.35 to -0.07 (FEM) and -0.35 to -0.08 (REM)) and -0.16 (95% CI: -0.30 to -0.03 (both FEM and REM)), respectively. However, no significant changes were noted in the SMD values when assessing medication use, quality of life (QoL), or peak expiratory flow rate (PEFR). In conclusion, air filters may help alleviate symptoms associated with AR; however, their effects on medication use, QoL, and PEFR appear to be limited. This systemic review and meta-analysis is registered with CRD42022380560.
AB - Previous studies have evaluated the effectiveness of air filters in mitigating the symptoms of allergic rhinitis (AR). However, these studies have yielded inconsistent results. This systematic review and meta-analysis was conducted to assess the effectiveness of air filters for patients with AR. For this, we comprehensively searched the PubMed, Embase, and Cochrane Library databases to identify relevant articles. The results are presented in terms of standardized mean difference (SMD) and 95% confidence intervals (CI) values with the fixed-effects model (FEM) and random-effects model (REM). Eight randomized controlled trials were included in our meta-analysis. Of these, three had a parallel design and five had a crossover design. Regarding clinical outcomes, pooled analyses performed using patients' nighttime and daytime symptom scores revealed SMD values of -0.21 (95% CI: -0.35 to -0.07 (FEM) and -0.35 to -0.08 (REM)) and -0.16 (95% CI: -0.30 to -0.03 (both FEM and REM)), respectively. However, no significant changes were noted in the SMD values when assessing medication use, quality of life (QoL), or peak expiratory flow rate (PEFR). In conclusion, air filters may help alleviate symptoms associated with AR; however, their effects on medication use, QoL, and PEFR appear to be limited. This systemic review and meta-analysis is registered with CRD42022380560.
UR - http://www.scopus.com/inward/record.url?scp=85188714776&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85188714776&partnerID=8YFLogxK
U2 - 10.1155/2024/8847667
DO - 10.1155/2024/8847667
M3 - Article
AN - SCOPUS:85188714776
SN - 0905-6947
VL - 2024
JO - Indoor Air
JF - Indoor Air
M1 - 8847667
ER -